[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"kb-reconstitute-cagrilintide-zh":3},{"_path":4,"_dir":5,"_draft":6,"_partial":6,"_locale":7,"title":8,"description":9,"date":10,"dateLabel":11,"updated":12,"read":13,"author":14,"image":15,"faq":16,"body":32,"_type":604,"_id":605,"_source":606,"_file":607,"_stem":608,"_extension":609},"\u002Freconstitute-cagrilintide\u002Fzh","reconstitute-cagrilintide",false,"","卡格列肽在溶液中：pH、聚集与原纤维","胰淀素类似物在水里的表现不同于普通冻干肽。pH 最优值究竟指的是什么、原纤维在结构上是什么，以及溶解度化学能回答到哪一步。","2026-07-03","2026年7月","2026-09-04","9 分钟","myPeptides Team","\u002Fassets\u002Freconstitute-cagrilintide_hero.png",[17,20,23,26,29],{"q":18,"a":19},"为什么一谈卡格列肽就总要提 pH 4","制剂文献把 4 附近的弱酸性环境描述为胰淀素类似物的稳定性最优值。这个数字对应的是密封状态下数年的有效期，而不是低温保存数周的溶液。卡格列肽属于临床在研化合物，未获批准作为药品上市。",{"q":21,"a":22},"胰淀素类似物为什么比其他肽更容易聚集","胰淀素家族的序列有文献记载的自缔合倾向，正因如此，这一类别的类似物才在设计上引入了用来削弱该倾向的替换位点。所以在这里，溶解度对 pH、温度和机械应力的依赖比大多数冻干肽都更强。",{"q":24,"a":25},"原纤维是什么，它和溶解状态的肽有什么区别","原纤维是错误折叠的肽链堆叠成的交叉 β-折叠结构，形成细长、刚性、基本不溶的丝状聚集体。溶解态的肽是可自由移动的单个分子，成熟原纤维则是固相沉积物，溶解度上的这一差别决定了其余的一切。",{"q":27,"a":28},"稳定性研究里的聚集数据究竟测的是什么","它们出自强制降解试验：材料被刻意加热、振摇并连续施加数小时应力，以便从加速的时间尺度上外推有效期。这类条件与冷藏、静置的西林瓶不具可比性；含量测定值下降，也不等于减少的那部分都变成了原纤维。卡格列肽属于临床在研化合物，未获批准作为药品；本文不描述任何配制做法。",{"q":30,"a":31},"卡格列肽是获批药品吗","不是。卡格列肽是处于临床开发阶段的在研化合物，在欧盟、美国、英国和澳大利亚均无上市许可，相应地，人体长期安全性数据也很有限。",{"type":33,"children":34,"toc":585},"root",[35,43,49,55,60,73,79,84,103,115,124,129,141,153,165,174,179,184,189,202,207,212,224,230,260,268,273,278,401,406,411,417,421,425,429,434,438,442,446,450,454,459,577],{"type":36,"tag":37,"props":38,"children":40},"element","h1",{"id":39},"卡格列肽在溶液中ph聚集与原纤维",[41],{"type":42,"value":8},"text",{"type":36,"tag":44,"props":45,"children":46},"p",{},[47],{"type":42,"value":48},"卡格列肽是一种仍在临床试验阶段、未获批准作为药品的胰淀素类似物，而围绕它始终有两种说法：一是它必须维持在 pH 4，二是高于这个 pH 生成的东西从长远看是危险的。两者归根到底都是溶解度问题，本页也就停在这条边界之内——胰淀素类似物的 pH 行为、聚集体在物理上究竟是什么，以及这场争论里有哪些部分是化学解决不了的。",{"type":36,"tag":50,"props":51,"children":53},"h2",{"id":52},"这是一类什么样的分子",[54],{"type":42,"value":52},{"type":36,"tag":44,"props":56,"children":57},{},[58],{"type":42,"value":59},"卡格列肽是胰淀素的长效类似物，实验室代号 AM833，结构上与普兰林肽相近。胰淀素是胰腺与胰岛素一同分泌的激素，而胰淀素家族是自缔合的教科书案例：这类序列倾向于彼此堆叠，而不是分散着待在溶液里。也正因如此，这一类别的类似物普遍带有脯氨酸替换和其他稳定化改造，用来减缓这一倾向。",{"type":36,"tag":44,"props":61,"children":62},{},[63,65,71],{"type":42,"value":64},"有两条状态事实为下文划定了范围。卡格列肽",{"type":36,"tag":66,"props":67,"children":68},"strong",{},[69],{"type":42,"value":70},"处于临床开发阶段，在欧盟、美国、英国和澳大利亚均未获得上市许可",{"type":42,"value":72},"，相应地，长时间跨度上的人体安全性数据也很少。以下内容不涉及任何配制方法。",{"type":36,"tag":50,"props":74,"children":76},{"id":75},"ph-为什么总被提起",[77],{"type":42,"value":78},"pH 为什么总被提起",{"type":36,"tag":44,"props":80,"children":81},{},[82],{"type":42,"value":83},"这个说法的底子是站得住的。针对胰淀素类似物的稳定性研究描述了一个弱酸性的最优区间，位置在 pH 4 附近，分子在此降解最慢；在中性 pH 下，报告的降解速率更高。",{"type":36,"tag":44,"props":85,"children":86},{},[87,89,94,96,101],{"type":42,"value":88},"背后的化学是普通的肽化学，主要有两条途径。",{"type":36,"tag":66,"props":90,"children":91},{},[92],{"type":42,"value":93},"水解",{"type":42,"value":95},"，尤其是天冬酰胺和谷氨酰胺残基的脱酰胺，随 pH 向中性靠拢而加快。",{"type":36,"tag":66,"props":97,"children":98},{},[99],{"type":42,"value":100},"净电荷",{"type":42,"value":102},"也在移动：当每个分子都带着同号强电荷，静电斥力让它们彼此保持距离；而当一条肽靠近自身的等电点，这层斥力消失，自缔合就变得容易。酸性条件把这两件事一并办了——制剂研究者若以数年密封有效期为目标，最终选定的通常就是这个区间。",{"type":36,"tag":44,"props":104,"children":105},{},[106,108,113],{"type":42,"value":107},"pH 4 这个数字通常也正是在这里被读错。有效期最优值回答的是“密封的物料如何存放数年”，而不是“低温溶液在数周里会发生什么”。抑菌注射用水的 pH 更接近 5.5 到 6。在该 pH 下的降解，在这一类肽已发表的降解动力学中被描述为渐进的，并且强烈依赖温度。另有一项针对",{"type":36,"tag":66,"props":109,"children":110},{},[111],{"type":42,"value":112},"加了保护性辅料",{"type":42,"value":114},"的胰淀素类似物制剂的稳定性研究报告：30 °C 放置五周后回收率高于 95%，而同一条肽在缺少该保护性辅料时低于 70%。这些数字描述的是特定条件下的受保护制剂，不能移植到没有缓冲体系的溶液上。",{"type":36,"tag":116,"props":117,"children":118},"tip",{},[119],{"type":36,"tag":44,"props":120,"children":121},{},[122],{"type":42,"value":123},"这里被混为一谈的是两个问题：密封物料存放数年所对应的 pH，和低温溶液维持数周所对应的 pH。为前者给出的最优值，不是后者的门槛。",{"type":36,"tag":50,"props":125,"children":127},{"id":126},"原纤维在结构上到底是什么",[128],{"type":42,"value":126},{"type":36,"tag":44,"props":130,"children":131},{},[132,134,139],{"type":42,"value":133},"原纤维有精确的结构定义，而这个定义本身就完成了大部分解释工作。肽链错误折叠成扁平的 β-折叠构象，这些片层再层层堆叠，结果是一条细长、刚性的交叉 β 丝状体，基本",{"type":36,"tag":66,"props":135,"children":136},{},[137],{"type":42,"value":138},"不溶",{"type":42,"value":140},"。在溶解态单体与成熟原纤维之间，还排着一串中间体——二聚体、寡聚体、前原纤维（protofibril）——它们仍然可溶，也仍然能移动。",{"type":36,"tag":44,"props":142,"children":143},{},[144,146,151],{"type":42,"value":145},"一旦有人把稳定性数据抽离语境来引用，这条进程就要紧起来了。文献里的聚集数字来自",{"type":36,"tag":66,"props":147,"children":148},{},[149],{"type":42,"value":150},"强制降解试验",{"type":42,"value":152},"：材料被刻意加热、高速振摇、连续施加数十小时应力，好让有效期模型能从加速的时间尺度上外推出来。这套方法学是标准化的，例如 ICH 稳定性指导原则中的规定，其设计初衷就是要远比任何贮存条件都苛刻。即便在这样的处理下，这一类肽已发表的降解动力学也把水解断裂成更小片段列为与聚集并行的主要途径（Kenley 等，2000），因此从含量测定中消失的肽，只有一部分能算到原纤维头上。测定信号的损失，和一支装满原纤维的西林瓶，不是同一个结论。",{"type":36,"tag":44,"props":154,"children":155},{},[156,158,163],{"type":42,"value":157},"第二条物理事实关乎迁移能力，这里与其下断言，不如看文献怎么写。不溶是成熟原纤维的定义性性质；而关于会形成聚集体的注射用肽，临床文献描述的是沉积物停留在原处，并不向别处迁移。记录得最充分的案例是胰岛素，综述文章在这方面报告的是",{"type":36,"tag":66,"props":159,"children":160},{},[161],{"type":42,"value":162},"给药部位的局部沉积与局部组织反应",{"type":42,"value":164},"，而不是在全身范围内的分布。这批工作针对的是胰岛素而非胰淀素类似物，它记录的是已经被观察到的现象——不是对另一个分子的担保。",{"type":36,"tag":44,"props":166,"children":167},{},[168],{"type":36,"tag":169,"props":170,"children":173},"img",{"alt":171,"src":172},"酸性 pH 下稳定的单个分子，与中性 pH 下缠结成束的丝状体对比","\u002Fassets\u002Fcagri_ph.png",[],{"type":36,"tag":50,"props":175,"children":177},{"id":176},"化学能回答到哪一步",[178],{"type":42,"value":176},{"type":36,"tag":44,"props":180,"children":181},{},[182],{"type":42,"value":183},"网上流传的那个说法把三句话串成了一条链：高于 pH 4 的溶液会产生原纤维；这些原纤维会穿行到身体各处；它们抵达别处会造成长期损害。",{"type":36,"tag":44,"props":185,"children":186},{},[187],{"type":42,"value":188},"前两句是化学问题，上面几节就是化学所能给出的回答，能给到的也就这么多：强制降解条件不是贮存条件，而成熟原纤维的不溶性正是文献所描述的性质。第三句根本不是化学问题。它属于临床与生物学，在研究文献中确实悬而未决，本页也不打算替它下结论。",{"type":36,"tag":44,"props":190,"children":191},{},[192,194,200],{"type":42,"value":193},"把相反的解读也一并讲清楚，同样是这里该做的事。有研究者主张成熟原纤维并不是该盯着的对象，因为早期的小聚集体——也就是上文提到的寡聚体——才是具有生物学相关性的物种，而它们",{"type":36,"tag":195,"props":196,"children":197},"em",{},[198],{"type":42,"value":199},"确实",{"type":42,"value":201},"小到足以移动。这是一场开放的争论，两个方向都还谈不上有定论；何况一个仍处在临床试验中的化合物，无论朝哪边看，人体长期数据都有限。这一类问题该交给原始文献和有执业资格的临床医生，而不是一个讲溶解度的页面。",{"type":36,"tag":50,"props":203,"children":205},{"id":204},"酸性最优值在制剂化学里为什么存在",[206],{"type":42,"value":204},{"type":36,"tag":44,"props":208,"children":209},{},[210],{"type":42,"value":211},"既然那个酸性最优值是真实存在的，这一类别的制剂文献里就会出现有缓冲体系的酸性介质，理由也就是上文已经写清楚的化学：更低的 pH 让水解变慢，也让每个分子保持更强的同号电荷。这就是它全部的化学作用，也正是 pH 4 这个数字所指的那件事。",{"type":36,"tag":44,"props":213,"children":214},{},[215,217,222],{"type":42,"value":216},"同一批文献把代价也一并记了下来。",{"type":36,"tag":66,"props":218,"children":219},{},[220],{"type":42,"value":221},"低 pH 的注射用制剂被描述为耐受性不如接近中性的制剂",{"type":42,"value":223},"，因此让一支密封西林瓶最稳定的 pH，并不是一个成品药最终灌装时所用的 pH。这两点都是对某一类分子已发表制剂实践的描述，都不特指卡格列肽。",{"type":36,"tag":50,"props":225,"children":227},{"id":226},"浓度质量与体积",[228],{"type":42,"value":229},"浓度、质量与体积",{"type":36,"tag":44,"props":231,"children":232},{},[233,235,242,244,250,252,258],{"type":42,"value":234},"有一段算术值得单独拎出来，因为它与具体物质无关，对任何溶液都成立。浓度是一个比值：质量除以体积。改变液体的体积，改变的是浓度，而不是已经在里面的肽的质量——物质既不增加也不减少，只是分布在更多或更少的液体里。这层关系跟某一条肽、某一种介质或某一个 pH 都没有关系。它写在",{"type":36,"tag":236,"props":237,"children":239},"a",{"href":238},"\u002Fmg-ml-iu",[240],{"type":42,"value":241},"mg、mL 和 IU 究竟是什么意思",{"type":42,"value":243},"里，用在",{"type":36,"tag":236,"props":245,"children":247},{"href":246},"\u002Freconstitute-peptides",[248],{"type":42,"value":249},"复溶的基础知识",{"type":42,"value":251},"中，也由",{"type":36,"tag":236,"props":253,"children":255},{"href":254},"\u002Fcalculator",[256],{"type":42,"value":257},"单位换算器",{"type":42,"value":259},"负责算出来。",{"type":36,"tag":44,"props":261,"children":262},{},[263],{"type":36,"tag":169,"props":264,"children":267},{"alt":265,"src":266},"两份体积里装着同样多的物质：小的那份挨得紧，大的那份被摊得更薄","\u002Fassets\u002Fcagri_concentration.png",[],{"type":36,"tag":50,"props":269,"children":271},{"id":270},"真正有文献记载的稳定性变量",[272],{"type":42,"value":270},{"type":36,"tag":44,"props":274,"children":275},{},[276],{"type":42,"value":277},"贮存化学是这个话题里争议最小的部分，也是发表依据最清楚的部分。",{"type":36,"tag":279,"props":280,"children":281},"table",{},[282,306],{"type":36,"tag":283,"props":284,"children":285},"thead",{},[286],{"type":36,"tag":287,"props":288,"children":289},"tr",{},[290,296,301],{"type":36,"tag":291,"props":292,"children":293},"th",{},[294],{"type":42,"value":295},"变量",{"type":36,"tag":291,"props":297,"children":298},{},[299],{"type":42,"value":300},"化学上的描述",{"type":36,"tag":291,"props":302,"children":303},{},[304],{"type":42,"value":305},"为何在这一类别里权重更大",{"type":36,"tag":307,"props":308,"children":309},"tbody",{},[310,329,347,365,383],{"type":36,"tag":287,"props":311,"children":312},{},[313,319,324],{"type":36,"tag":314,"props":315,"children":316},"td",{},[317],{"type":42,"value":318},"温度",{"type":36,"tag":314,"props":320,"children":321},{},[322],{"type":42,"value":323},"水解与脱酰胺随温度下降而显著减慢；2–8 °C 是标准参照区间",{"type":36,"tag":314,"props":325,"children":326},{},[327],{"type":42,"value":328},"降解越慢，走向易聚集状态的进程也越慢",{"type":36,"tag":287,"props":330,"children":331},{},[332,337,342],{"type":36,"tag":314,"props":333,"children":334},{},[335],{"type":42,"value":336},"冻结",{"type":36,"tag":314,"props":338,"children":339},{},[340],{"type":42,"value":341},"反复冻融被报告会通过冰界面应力和局部浓缩效应损伤肽溶液",{"type":36,"tag":314,"props":343,"children":344},{},[345],{"type":42,"value":346},"界面应力是自缔合序列已知的成核途径",{"type":36,"tag":287,"props":348,"children":349},{},[350,355,360],{"type":36,"tag":314,"props":351,"children":352},{},[353],{"type":42,"value":354},"振摇",{"type":36,"tag":314,"props":356,"children":357},{},[358],{"type":42,"value":359},"摇动产生气液界面和剪切，两者都被描述为促进成核",{"type":36,"tag":314,"props":361,"children":362},{},[363],{"type":42,"value":364},"受应力的研究样品与静置的西林瓶之间，差别最大的一项",{"type":36,"tag":287,"props":366,"children":367},{},[368,373,378],{"type":36,"tag":314,"props":369,"children":370},{},[371],{"type":42,"value":372},"光照",{"type":36,"tag":314,"props":374,"children":375},{},[376],{"type":42,"value":377},"光降解作用于芳香族残基；避光贮存是参照做法",{"type":36,"tag":314,"props":379,"children":380},{},[381],{"type":42,"value":382},"属于肽的通性，而非这一类别的特有性质",{"type":36,"tag":287,"props":384,"children":385},{},[386,391,396],{"type":36,"tag":314,"props":387,"children":388},{},[389],{"type":42,"value":390},"介质 pH",{"type":36,"tag":314,"props":392,"children":393},{},[394],{"type":42,"value":395},"酸性条件减慢水解，并增强同号电荷之间的斥力",{"type":36,"tag":314,"props":397,"children":398},{},[399],{"type":42,"value":400},"pH 4 这个数字的由来",{"type":36,"tag":44,"props":402,"children":403},{},[404],{"type":42,"value":405},"这些都不是卡格列肽独有的，它们是通用的肽溶液化学，也正是一项稳定性研究与普通冷藏保存分道扬镳的地方。",{"type":36,"tag":50,"props":407,"children":409},{"id":408},"常见问题",[410],{"type":42,"value":408},{"type":36,"tag":412,"props":413,"children":415},"h3",{"id":414},"为什么一谈卡格列肽就总要提-ph-4",[416],{"type":42,"value":18},{"type":36,"tag":44,"props":418,"children":419},{},[420],{"type":42,"value":19},{"type":36,"tag":412,"props":422,"children":423},{"id":21},[424],{"type":42,"value":21},{"type":36,"tag":44,"props":426,"children":427},{},[428],{"type":42,"value":22},{"type":36,"tag":412,"props":430,"children":432},{"id":431},"原纤维是什么它和溶解状态的肽有什么区别",[433],{"type":42,"value":24},{"type":36,"tag":44,"props":435,"children":436},{},[437],{"type":42,"value":25},{"type":36,"tag":412,"props":439,"children":440},{"id":27},[441],{"type":42,"value":27},{"type":36,"tag":44,"props":443,"children":444},{},[445],{"type":42,"value":28},{"type":36,"tag":412,"props":447,"children":448},{"id":30},[449],{"type":42,"value":30},{"type":36,"tag":44,"props":451,"children":452},{},[453],{"type":42,"value":31},{"type":36,"tag":50,"props":455,"children":457},{"id":456},"参考与延伸阅读",[458],{"type":42,"value":456},{"type":36,"tag":460,"props":461,"children":462},"ul",{},[463,477,496,508,527,548,560],{"type":36,"tag":464,"props":465,"children":466},"li",{},[467,469],{"type":42,"value":468},"研发状态：",{"type":36,"tag":236,"props":470,"children":474},{"href":471,"rel":472},"https:\u002F\u002Fclinicaltrials.gov\u002Fsearch?intr=cagrilintide",[473],"nofollow",[475],{"type":42,"value":476},"ClinicalTrials.gov，cagrilintide",{"type":36,"tag":464,"props":478,"children":479},{},[480,482,487,489],{"type":42,"value":481},"降解随 pH 与温度的变化：Kenley RA, Tracht S, Stepanenko A, \"Kinetics of pramlintide degradation in aqueous solution as a function of temperature and pH\", ",{"type":36,"tag":195,"props":483,"children":484},{},[485],{"type":42,"value":486},"AAPS PharmSciTech",{"type":42,"value":488}," 2000;1(2):E7 — ",{"type":36,"tag":236,"props":490,"children":493},{"href":491,"rel":492},"https:\u002F\u002Fpubmed.ncbi.nlm.nih.gov\u002F14727840\u002F",[473],[494],{"type":42,"value":495},"PubMed 14727840",{"type":36,"tag":464,"props":497,"children":498},{},[499,501],{"type":42,"value":500},"加了保护性辅料的胰淀素类似物溶液的稳定性：\"Compositions in the form of an injectable aqueous solution comprising amylin, an amylin receptor agonist or an amylin analog, and a co-polyamino acid\"，专利 US 10,463,717 B2（Adocia SAS，2019）— ",{"type":36,"tag":236,"props":502,"children":505},{"href":503,"rel":504},"https:\u002F\u002Fpatents.google.com\u002Fpatent\u002FUS10463717B2\u002Fen",[473],[506],{"type":42,"value":507},"Google Patents",{"type":36,"tag":464,"props":509,"children":510},{},[511,513,518,520],{"type":42,"value":512},"注射用肽聚集体的局部沉积：Ansari AM, Osmani L, Matsangos AE, et al., \"Current insight in the localized insulin-derived amyloidosis (LIDA): clinico-pathological characteristics and differential diagnosis\", ",{"type":36,"tag":195,"props":514,"children":515},{},[516],{"type":42,"value":517},"Pathology - Research and Practice",{"type":42,"value":519}," 2017;213(10):1237–1241 — ",{"type":36,"tag":236,"props":521,"children":524},{"href":522,"rel":523},"https:\u002F\u002Fpubmed.ncbi.nlm.nih.gov\u002F28935176\u002F",[473],[525],{"type":42,"value":526},"PubMed 28935176",{"type":36,"tag":464,"props":528,"children":529},{},[530,532,539,541],{"type":42,"value":531},"更多原始文献：",{"type":36,"tag":236,"props":533,"children":536},{"href":534,"rel":535},"https:\u002F\u002Fpubmed.ncbi.nlm.nih.gov\u002F?term=cagrilintide",[473],[537],{"type":42,"value":538},"PubMed，cagrilintide",{"type":42,"value":540}," 与 ",{"type":36,"tag":236,"props":542,"children":545},{"href":543,"rel":544},"https:\u002F\u002Fpubmed.ncbi.nlm.nih.gov\u002F?term=amylin+analogue+aggregation",[473],[546],{"type":42,"value":547},"PubMed，amylin analogue aggregation",{"type":36,"tag":464,"props":549,"children":550},{},[551,553],{"type":42,"value":552},"稳定性方法学：",{"type":36,"tag":236,"props":554,"children":557},{"href":555,"rel":556},"https:\u002F\u002Fwww.ich.org\u002Fpage\u002Fquality-guidelines",[473],[558],{"type":42,"value":559},"ICH 质量指导原则，Q1 系列",{"type":36,"tag":464,"props":561,"children":562},{},[563,565,569,571],{"type":42,"value":564},"站内相关：",{"type":36,"tag":236,"props":566,"children":567},{"href":246},[568],{"type":42,"value":249},{"type":42,"value":570},"、",{"type":36,"tag":236,"props":572,"children":574},{"href":573},"\u002Fbacteriostatic-vs-sterile-water",[575],{"type":42,"value":576},"抑菌注射用水与无菌注射用水",{"type":36,"tag":44,"props":578,"children":579},{},[580],{"type":36,"tag":195,"props":581,"children":582},{},[583],{"type":42,"value":584},"本页只讨论溶解度与稳定性化学。卡格列肽属于临床在研化合物，未获批准作为药品；文中不给出、也不暗示任何配制或使用建议。",{"title":7,"searchDepth":586,"depth":586,"links":587},2,[588,589,590,591,592,593,594,595,603],{"id":52,"depth":586,"text":52},{"id":75,"depth":586,"text":78},{"id":126,"depth":586,"text":126},{"id":176,"depth":586,"text":176},{"id":204,"depth":586,"text":204},{"id":226,"depth":586,"text":229},{"id":270,"depth":586,"text":270},{"id":408,"depth":586,"text":408,"children":596},[597,599,600,601,602],{"id":414,"depth":598,"text":18},3,{"id":21,"depth":598,"text":21},{"id":431,"depth":598,"text":24},{"id":27,"depth":598,"text":27},{"id":30,"depth":598,"text":30},{"id":456,"depth":586,"text":456},"markdown","content:reconstitute-cagrilintide:zh.md","content","reconstitute-cagrilintide\u002Fzh.md","reconstitute-cagrilintide\u002Fzh","md"]